Cargando…

Pain reduction induced by tapentadol in patients with musculoskeletal chronic pain fosters better sleep quality

BACKGROUND: Poor sleep may predict the increase and intensification of pain over time with increased insomnia symptoms being both a predictor and an indicator of worse pain outcomes and physical functioning status over time. However, the impact of different analgesic therapies on quality of life, fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vellucci, Renato, De Rosa, Gianluca, Piraccini, Emanuele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioExcel Publishing Ltd 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060026/ https://www.ncbi.nlm.nih.gov/pubmed/33953781 http://dx.doi.org/10.7573/dic.2020-12-9

Ejemplares similares

Lasting Prolonged-Release Tapentadol for Moderate/Severe Non-Cancer Musculoskeletal Chronic Pain
por: Samolsky Dekel, Boaz G., et al.
Publicado: (2015)

Prediction of response to tapentadol in chronic low back pain
por: Reimer, M., et al.
Publicado: (2016)

Tapentadol extended release for the management of chronic neck pain
por: Billeci, Domenico, et al.
Publicado: (2017)

Tapentadol extended-release for treatment of chronic pain: a review
por: Vadivelu, Nalini, et al.
Publicado: (2011)

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain
por: Pergolizzi, Joseph V., et al.
Publicado: (2018)

Tapentadol: an effective option for the treatment of back pain
por: Coluzzi, Flaminia, et al.
Publicado: (2019)

A Novel Algorithm to Identify Predictors of Treatment Response: Tapentadol Monotherapy or Tapentadol/Pregabalin Combination Therapy in Chronic Low Back Pain?
por: Otto, Jan C., et al.
Publicado: (2019)

Patient considerations in the use of tapentadol for moderate to severe pain
por: Vadivelu, Nalini, et al.
Publicado: (2013)

Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2018)

Tapentadol: an effective option for the treatment of back pain [Corrigendum]
Publicado: (2019)

Tapentadol for neuropathic pain: a review of clinical studies
por: Freo, Ulderico, et al.
Publicado: (2019)

Military Chronic Musculoskeletal Pain and Psychiatric Comorbidity: Is Better Pain Management the Answer?
por: McGeary, Cindy A., et al.
Publicado: (2016)

Tapentadol prolonged release for severe chronic cancer-related pain: effectiveness, tolerability, and influence on quality of life of the patients
por: Schikowski, Artur, et al.
Publicado: (2014)

Tapentadol extended release in the management of peripheral diabetic neuropathic pain
por: Vadivelu, Nalini, et al.
Publicado: (2015)

Correction to: Tapentadol Prolonged Release: A Review in Pain Management
por: Deeks, Emma D.
Publicado: (2019)

Tapentadol in the management of cancer pain: current evidence and future perspectives
por: Kress, Hans G, et al.
Publicado: (2019)

Tapentadol: a new option for the treatment of cancer and noncancer pains
por: Dickenson, Anthony H, et al.
Publicado: (2019)

Tapentadol Prolonged Release for Long-Term Treatment of Pain in Children
por: Howard, Richard F, et al.
Publicado: (2020)

Sleep, Experimental Pain and Clinical Pain in Patients with Chronic Musculoskeletal Pain and Healthy Controls
por: Stroemel-Scheder, Cindy, et al.
Publicado: (2019)

Chronic pain management in COVID-19 era
por: Piraccini, Emanuele, et al.
Publicado: (2020)

Tapentadol Prolonged Release Reduces the Severe Chronic Ischaemic Pain and Improves the Quality of Life in Patients with Type 2 Diabetes
por: Tedeschi, Anna, et al.
Publicado: (2018)

Tapentadol in the management of chronic low back pain: a novel approach to a complex condition?
por: Pergolizzi, Joseph, et al.
Publicado: (2011)

Effects of tapentadol on pain, motor symptoms and cognitive functions in Parkinson’s disease
por: Freo, Ulderico, et al.
Publicado: (2018)

Tapentadol treatment results in long-term pain relief in patients with chronic low back pain and associates with reduced segmental sensitization
por: van de Donk, Tine, et al.
Publicado: (2020)

The Effect of Sleep Quality on Pain in Chilean Individuals with Musculoskeletal Disorders
por: Bascour-Sandoval, Claudio, et al.
Publicado: (2021)

Management of Musculoskeletal Pain: An Update with Emphasis on Chronic Musculoskeletal Pain
por: El-Tallawy, Salah N., et al.
Publicado: (2021)

Clinical pharmacology of tramadol and tapentadol, and their therapeutic efficacy in different models of acute and chronic pain in dogs and cats
por: Domínguez-Oliva, Adriana, et al.
Publicado: (2021)

How does reduction in pain lead to reduction in disability in patients with musculoskeletal pain?
por: Shaygan, Maryam, et al.
Publicado: (2019)

Chronic widespread musculoskeletal pain in patients with obstructive sleep apnea syndrome and the relationship between sleep disorder and pain level, quality of life, and disability
por: Aytekin, Ebru, et al.
Publicado: (2015)

Tapentadol immediate release: a new treatment option for acute pain management
por: Afilalo, Marc, et al.
Publicado: (2010)

A combination pharmacotherapy of tapentadol and pregabalin to tackle centrally driven osteoarthritis pain
por: Lockwood, Stevie Margaret, et al.
Publicado: (2019)

Effectiveness and safety of tapentadol prolonged release with tapentadol immediate release on-demand for the management of severe, chronic osteoarthritis-related knee pain: results of an open-label, phase 3b study
por: Steigerwald, Ilona, et al.
Publicado: (2012)

Effects of an adapted mattress in musculoskeletal pain and sleep quality in institutionalized elders
por: Ancuelle, Victor, et al.
Publicado: (2015)

Effectiveness and Tolerability of Tapentadol Prolonged Release Compared With Prior Opioid Therapy for the Management of Severe, Chronic Osteoarthritis Pain
por: Steigerwald, Ilona, et al.
Publicado: (2013)

A Pooled Analysis Evaluating the Efficacy and Tolerability of Tapentadol Extended Release for Chronic, Painful Diabetic Peripheral Neuropathy
por: Schwartz, Sherwyn, et al.
Publicado: (2014)

Direct conversion from tramadol to tapentadol prolonged release for moderate to severe, chronic malignant tumour‐related pain
por: Kress, H.G., et al.
Publicado: (2016)

Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study
por: Barrachina, Jordi, et al.
Publicado: (2022)

Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study
por: Barrachina, Jordi, et al.
Publicado: (2022)

Tapentadol for the Treatment of Moderate-to-Severe Acute Pain in Children Under the Age of Two Years
por: Eissa, Ayman, et al.
Publicado: (2021)

Words that describe chronic musculoskeletal pain: implications for assessing pain quality across cultures
por: Sharma, Saurab, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eu9cjbnupdoc5vjkfcmg9fhvp3